such as, Sterol Regulatory Element-Binding Protein-lc (SREBP-lc) and
Phosphoenolpyruvate carboxykinase (PEPCK) are regulated by PPAR y [Auwerx, 1999; Tontonoz et al., 1995] . Activation of PPARy results in inhibition of expression of TNFa, which, in, turn, is an inhibitor of PPARy gene expression [Remels et al., 2008; Xing et al., 1997] , The notion that PPARy plays an important role in type 2 diabetes is supported by the recent evidence where families having mutations in PPARy suffered from severe insulin resistance, diabetes and hypertension [Barroso et al., 1999] . Several investigations have suggested that mitochondrial function might also play a pivotal role in the pathogenesis of insulin resistance and type 2 diabetes [Abdul-Ghani & Defronzo, 2008; Hojlund et al., 2008] . V
Obesity: an Overview
Obesity may be considered as the result of positive energy balance in the conditions of energy excess. Economic, social and lifestyle changes are responsible for this common condition of different populations living in environments characterized by abundant calorie rich food and low physical activity [Balistreri et al., 2010; Frayn et al., 1995; Gregoire et al., 1998 ]. The number of obese individuals world-wide is increasing at an alarming rate, leading to an explosion of obesity related health problems associated with increased morbidity and mortality [Balistreri et al., 2010; McTeman et al., 2005] . More than two thirds of American population is overweight which is common feature for other western population [Balistreri et al., 2010; Ogden et al.,2006 ]. The highest frequency in obesity is observed in United States, Europe [Pengelly & Morris, 2009] . Obesity predisposes to a variety of 12 | P a g e 'V o f Literature diseases, which includes insulin resistance, type 2 diabetes, hypertension, dyslipidemia, atherosclerosis and its complications, fatty liver diseases, osteoarthritis, rheumatoid arthritis, and cancer [Garg & Misra, 2002; Reaven, 1996; Schelbert, 2000] .
Adipose tissue can vary from 2-3% in athletes to 60-70% of body mass in the morbidly obese. There are two patterns of body fat distribution based on somatotypes, i.e android, or male pattern where fat is stored centrally and gynoid, or female pattern where fat is stored on hips and thighs [Amer, 1997] . In comparison with the gynoid obesity, android obesity is more frequently at a risk of diseases like diabetes mellitus, coronary artery disease, gout, and uric acid renal stones [Vague, 1956] . The adipose tissue mass depends upon either the number of adipocytes present or adipocyte volume or both [McTeman et al., 2005 ] . In case of increased energy intake hypertrophic (increased cell volume) and hyperplastic (increase in adipocyte number) growth can occur. This activity is regulated at the hormonal and genetic level with the help of key genes responsible for lipogenesis or lipolysis [Gregoire et al., 1998; McTeman et al., 2005] . Usually, adipose tissue contains a mixed group of adipocytes of different cell size. As fat mass increases, the adipose tissue loses its heterogeneity with more mature adipocytes having increased cell size [McTeman et al., 2005] .
There is a great controversy regarding the relative importance of subcutaneous versus visceral fat in the pathogenesis of metabolic syndrome.
Many in vitro and in vivo studies have suggested that visceral fat is responsible for the health risks associated with central obesity [McTeman et al., 2005] , Visceral fat which constitutes 6-20% of the total body fat volume is metabolically more active and the smaller visceral adipocytes are more responsive to the lipofytic effects of the catecholamines and less responsive to the anabolic effects of insulin [Engfeldt & Amer, 1998; Eriksson et al., 2000; Ostman et al., 1979] , Increased lipolysis results in greater nonesterified fatty acid (NEFA) release, which is implicated in development of insulin resistance [McTeman et al., 2005] . Studies in normal weight subjects, where insulin resistance is induced by lipid infusion have shown that excess NEFAs results in reduction in glucose uptake; glucose oxidation and glycogen synthesis [Ferrannini et al., 1983] . However, many studies contradict this and say that subcutaneous fat which constitutes 80% of the total body fat volume plays a significant role in the pathogenesis of central obesity associated disease [Amer et al., 1991; McTeman et al., 2005] , Evidence suggest that lipolysis within abdominal depots of subcutaneous adipose tissue is twice as high as the gluteofemoral adipose tissue in males [Amer et al., 1991] .
Adipose tissue as an endocrine organ
Adipocytes and adipose tissue are known to express and secrete a wide range of hormones and cytokines, which may act at both the local (autocrine and/or paracrine) and systemic (endocrine) level [Laclaustra et al., 2007] .
They are involved in glucose metabolism (e.g. adiponectin, resistin), lipid metabolism (e.g. cholesteiyl ester transfer protein, CETP), inflammation (e.g. TNFa, IL6), coagulation (PAI-1), blood pressure (e.g. angiotensinogen, angiotensin II), and feeding behaviour (leptin) thus affecting metabolism and 14 | P a g e icw of Lit function of many organs and tissues including muscle, liver, vasculature, and brain [Table 1 
Leptin
Leptin production is prominently augmented in large adipocytes [Considine et al., 1996; Hajer et al., 2008] , is induced by eating-related hormones, energy status, sex hormones (being inhibited by testosterone and increased by ovarian sex steroids) and several proinflammatoiy mediators [Hajer et al., 2008; Saladin et al., 1995; Zhang et al., 2000] . Leptin acts via melanocortdn system in the hypothalamus [ Cheung et al., 1997; Schwartz et al., 2000] , 2004] . It is also known to be involved in other processes, such as the proliferation of lymphocytes (particularly CD4+) and induction of Thl response, cytokine production, phagocytosis, and regulation of hypothalamic-pituitary-adrenal-axis, reproduction, angiogenesis, and oxidative stress [ Lago et al., 2007; Lago et al., 2009] . Leptin increases with obesity [Van Hermelen et al., 1998; Zimmet et al., 1996] and is associated in insulin resistance in type 2 diabetes and obesity through its regulation of the deposition of fat in insulin responsive tissues, rather than through its [Kershaw & Flier, 20041. 
Adiponectin
Adiponectin is exclusively produced by adipocytes. It circulates in plasma in three different full-length isoforms (trimer, hexamer, and multimers) and as globular form [Hajer et al., 2008; Kershaw & Flier, 2004] , Adiponectin increases fatty acid oxidation in both muscle and liver with reduction in plasma fatty acid levels, decreases plasma glucose levels, increases insulin sensitivity through inhibition of hepatic glucose production as shown in Adiponectin level is found to be reduced in obesity, insulin resistance, metabolic syndrome, and type 2 diabetes [Chandran et al., 2003; Diez & Iglesias, 2003; Hotta et al., 2001] , Adiponectin expression is higher in subcutaneous adipose tissue than in visceral adipose tissue [Fain et al., 2004; Kershaw & Flier, 2004] , Men have lower plasma adiponectin levels than women [Hajer et al., 2008] . Sveral polymorphisms in the adiponectin gene are associated with obesity and insulin resistance [Chandran et al., 2003; Diez & Iglesias, 2003 ] . Adiponectin level increase when insulin sensitivity improves as well as after weight reduction or treatment with insulin sensitizing drug [Chandran et al., 2003; Diez & Iglesias, 2003 ]. It has recently been shown that adiponectin expression and mitochondrial content in adipose tissue are reduced in obese db/db mice, and these 
Interleukin 6
IL6 is found to be associated with obesity and insulin resistance [Fernandez-Real & Ricart, 2003 ] and circulates in multiple glycosylated forms ranging from 22 to 27 kDa in size. IL6 is one of the crucial pro-inflammatory mediator, secreted by several body's cell types like monocytes, adipocytes, endothelial cells, fibroblasts, etc. [Cancello & Cl'ement, 2006; Juge-Aubry et al., 2005] . Expression and secretion of IL6 are 2 to 3 times greater in visceral adipose tissue compared to subcutaneous adipose tissue [Fain et al., 2004; Wajchenberg, 2000] . One third of circulating IL6 originates from adipose tissue [Fernandez-Real & Ricart, 2003 ]. IL6 has varied effects on muscle, adipose tissue, liver and brain [Fig. 4] [Kershaw 8s Flier, 2004] .
Adipose tissue IL6 expression as well as circulating IL6 concentrations are positively correlated with obesity, impaired glucose tolerance, and insulin resistance [Fernandez-Real 8s Ricart, 2003 ]. Both expression and circulating levels of IL6 have been found to decrease with weight loss [Fernandez-Real 8s Ricart, 2003 ]. Furthermore, genetic polymorphisms of the IL6 locus have been linked to obesity, energy expenditure, insulin sensitivity, and type 2 diabetes [Fernandez-Real 8s Ricart, 2003] . Peripheral administration of IL6 induces hyperlipidemia, hyperglycemia, and insulin resistance in rodents and humans [Fernandez-Real & Ricart, 2003 ] . IL6 inhibits adipogenesis and decreases adiponectin secretion [Fernandez-Real & Ricart, 2003 ], 
.4. Tumour Necrosis Factor a
TNFa is another important proinflammatory cytokine and is the first adipokine to be directly associated with insulin resistance [Pekala et al., 1983] . Asociations between the expression of TNFa in adipose tissue and obesity and insulin resistance has been reported in both humans and animals [Hotamisligil et al.,1993; Hotamisligil et al., 1995] . There is accumulating evidence showing its capacity to modulate components of the insulin signaling cascade, its effect on fat oxidation and adipocyte apoptosis and the expression and activity of the other adipokines [Clarke 85 Mohamed-Ali, 2005] . The role of TNFa has been discussed earlier.
Type 2 diabetes and obesity: metabolic dysfunction
Obesity is considered as one of the most important risk factor for type 2 diabetes [Chan et al., 1994; Reaven, 1988] . Obesity, body fat distribution and weight gain throughout adulthood are important predictors of diabetes [Chan et al., 1994; Goossens, 2008; Hans et al., 1998 ]. The cause and effect relationship between obesity and insulin resistance is well known [Bak et al., 1992; Friedman et al., 1992] . Adipose tissue dysfunction plays a pivotal role in the etiopathogenesis of obesity-related insulin resistance and type 2 diabetes. Enlarged adipocytes, ectopic fat storage, impaired adipose tissue blood flow, local inflammation, macrophage infiltration seems to be interrelated and lead to the development and/or progression of insulin resistance and ultimately to type 2 diabetes [Goossens, 2008] . [Goossens, 2008] , Many recent studies have suggested that NEFAs induce different isoforms of protein kinase C which interfere with the intracellular signaling pathway of insulin and ultimate^ block glucose transport activity [Griffin et al., 1999] .
Ectopic fat storage syndrome
Adipose tissue helps in buffering the daily influx of dietary fat entering the circulation by suppressing the release of NEFAs into the circulation and by increasing the clearance of triacylglycerol (TAG) [Goossens, 2008] . In obesity, adipose tissue becomes overloaded with TAG and the buffering capacity of adipocytes is reduced in the postprandial state [Frayn, 2001 , Goossens, 2008 . This causes an influx of TAG and fatty acids which results in the storage of triacylglycerol and other lipid moieties in non-adipose tissues like skeletal muscle [Forouhi et al., 1999; Jacob et al., 1999 al., 1997] , liver [Baneiji et al., 1995; Bjomtorp et al., 1995] , and pancreatic P cells [Koyama et al., 1997] . Ectopic fat storage plays an important role in the development of insulin resistance and/or impaired insulin secretion [Goossens, 2008] [Fig. 5 ].
Adipose tissue blood flow in lipid metabolism
Blood flow helps in regulating metabolism in both muscle and adipose tissue [Baron 8s Clark, 1997; Bulow 8b Madsen, 1981; Galitzky et al., 1993; Samra et al., 1996] . Evidence suggests that disturbances in adipose tissue blood flow (ATBF) may affect adipose tissue lipid handling. This results in increased lipid supply to non-adipose tissues, which in turn may lead to ectopic fat deposition as discussed earlier [Ardilouze et al., 2004; Bulow et al., 1987; Coppack et al., 1992; Evans et al., 1999] . It has been suggested that in obesity, both fasting ATBF and ATBF responsiveness to nutrients are reduced [Blaak et al., 1995; Goossens et al., 2007; Jansson et al., 1998; Summers et al., 1996; Virtanen et al., 2002 ]. An impaired postprandial ATBF seems to be associated with insulin resistance [Jansson et al., 1998; Karpe et al., 2002] . It has been reported that in obese compared to lean subjects, plasma TAG extraction in adipose tissue is decreased in the fasting and postprandial state [Potts et al., 1995] .
Adipose tissue inflammation and macrophage infiltration
Adipose tissue is a heterogeneous tissue and consists of different types of cells, including mature adipocytes, preadipocytes, endothelial cells, vascular smooth muscle cells, leukocytes, monocytes and macrophages [Goossens, 2008] . Macrophages are non-adipocjhe cells which contribute to adipose tissue production of inflammatory cytokines except for adiponeetin and leptin which are primarily secreted by adipocytes [Fain, 2006; Goossens, 2008] . As obesity develops, adipose tissue gets infiltrated by more and more macrophages [Weisberg et al., 2003; Xu et al., 2003] Moreover, deficient mitochondrial metabolism may generate ROS which can damage the tissue compartments or alters the cell signalling pattern. The gradients of ADP and ATP across the inner membrane are equilibrated by the adenine nucleotide translocase activity, which is functional to provide ADP to the matrix and ATP for energy-dependent processes to the cytosol. Fig. 9 : Mitochondrial ROS production and defense. Superoxide (02 ) generated by the respiratory chain is mostly released to the matrix at complex 1 and the IMS at complex III (indicated by stars). 02' can naturally dismute to hydrogen peroxide (H202) or is enzymatically dismuted by matrix Mn-SOD (1) or Cu/ZnSOD (2) in the IMS or cytosol. H202 is detoxified in the matrix by catalase (3), the thioredoxin/thioredoxin peroxidase system (4), or the glutathione/glutathione peroxidase system (5). Alternately, H202 can react with metal ions to generate the highly reactive hydroxyl radical (.OH) via Fenton chemistry (6). 02' is not membrane permeable but can pass through ion channels (solid lines), whereas H202 can pass freely through membranes (dashed lines). IMM, inner mitochondrial membrane; IMS, intermembrane space; OMM, outer mitochondrial membrane; Mn-SOD, manganese superoxide dismutase; Cu/ZnSOD, copper/zinc superoxide dismutase; CAT,catalase; THD, NADH transhydrogenase; TR, thioredoxin reductase; TPx, thioredoxin peroxidase; TRxred, reducedthioredoxin; TRxox, oxidized thioredoxin; GSH, glutathione; GSSG, glutathione disulfide; IMAC, inner membrane ion channel; VDAC, voltage dependant anion channel; ATm, membrane potential. [Feissneret al., 2009] Several sites of mitochondrial ROS production have been identified using isolated mitochondria respiring with different substrates [Murphy, 2009] . 
Mitochondria and its functions: an overview

ROS production in mitochondria
Mitochondrial biogenesis
Mitochondrial biogenesis is a complex process which involves multiplication of mtDNA, increase in mitochondrial mass and proliferation of mitochondria 
Fig. 12: Transcriptional control of mitochondrial biogenesis
Several factors like NRF 1 (nuclear respiratory factor 1), NRF 2 (nuclear respiratory factor 2), PPARa , ERRa (estrogen receptor-related receptor a), Spl (specificity protein 1) and Tfam take part in this process. They together bring about the co-ordination between the mitochondrial and nuclear genome necessary for biogenesis [Kelly & Scarpulla, 2004; Lee, 2005; Scarpulla, 2008] . The target genes for these transcription factors especially of NRF 1, NRF 2, Sp 1 and Tfam have been identified and they work in Scarpulla, 2004; Scarpulla, 2008] . PGC la has an inducible nature and is regulated by cyclic AMP (cAMP) and cyclic AMP response element-binding protein (CREB), AMP activated protein kinase, calcium/calmodulindependent protein kinase 1ype IV (CAMK IV), endothelial nitric oxide synthase (eNOS) etc [Cheng et al., 2011; Kelly & Scarpulla, 2004; Zong et al., 2002] . Mitochondrial fission is carried out with the help of dynamin related protein 1 (DRP1) for the outer membrane and OPA1 for the inner membrane of mitochondria while mitofusins (Mfn) control mitochondrial fusion [Patti & Corvera, 2010 ].
Relationship between mitochondrial biogenesis and ROS
Several studies indicate how ROS can induce Tfam or NRF 1 to initiate mitochondrial biogenesis. In rat hepatoma cells, the induction of Tfam by redox activation of NRF 1 through Akt dependent phosphorylation has been shown [Piantadosi 8b Suliman, 2006] . Likewise mitochondrial binding of CO leads to increased formation of H2O2 which is often linked to Akt activation and activation of NRF 1, NRF 2 and Tfam [Suliman et al., 2007] . In human endothelial cells, homocysteine is found to induce ROS production which activates mitochondrial biogenesis through involvement of NRF 1 and Tfam [Zinellu et al., 2009] . In HeLa cells with depleted mtDNA, the increase in endogenous ROS has been shown to activate mitochondrial biogenesis through the involvement of NRF 1 and Tfam [Lee et al., 2005] . Another study has elucidated the molecular pathway of ROS-dependent activation and nuclear translocation of Nrf 2 (Nuclear factor eiythroid-2 related factor 2).
The Nrf 2 in turn causes promoter activation of NRF 1 to start mitochondrial biogenesis programme [Piantadosi et al., 2008] . Other studies have also reported down-regulation of mitochondrial biogenesis by increased ROS [Chevtzoff et al., 2010 ]. It appears when mitochondrial functional impairment is mild to moderate, ROS may tiy to compensate it by stimulating mitochondrial biogenesis, but which in turn may lead to an overload of ROS production which can further damage the cellular components including the mitochondria [Chakrabarti et al., 2011], 
Roles of mitochondria in adipose tissue
Although the important role of mitochondria in brown adipose tissue and muscles has been highlighted often in the literature, several recent studies indicate that mitochondrial density increases remarkbly during differentiation in white adipose tissue and the mitochondria in the latter group have diverse type of proteins than mitochondria from heart, skeletal muscle or brain [Kim et al., 2004; Luo et al., 2008; Wilson-Fritch et al., 2003 ]. The most important functions performed by mitochondria in white adipose tissue are the anaplerotic generation of metabolic intermediates for fatty acid synthesis and esterification [Owen et at., 2002] , the maintenance of adiponectin synthesis, folding and secretion [Koh et al., 2007] , and the modulation of interactions of the insulin signaling pathway [Shi et al., 2008] .
The relevance of white adipocyte mitochondria to whole-body metabolism and metabolic disease may depend on the extent to which mitochondrial respiratory capacity and/or the total mass of white adipose tissue will be sufficient to impact circulating free fatty acid levels. Higher mitochondrial density and even uncoupler protein 1 (UCP1) can be induced in response to pharmacological or genetic alterations of white adipocytes [Bogaka et al., 2005; Hims-Hagen et al., 2000; Loncar, 1991; Orci et al., 2004; Strom et al., 2008; Tiraby et al., 2003; Toh et al., 2008; Wilson-Fritch et al., 2004] . These 
Evidence for reduced adipose tissue mitochondrial capacity in diabetes and obesity
White adipocyte mitochondrial content is decreased in both rodent and human obesity [Choo et al., 2006; Okamoto et al., 2007; Rong et al., 2007; Sutherland et al., 2008; Wilson-Fritch et al., 2004] which correlates with insulin resistance that accompanies obesity. In humans, white adipocyte mtDNA copy number is found to be inversely correlated with age and BMI and directly correlated with basal and insulin-induced lipogenesis [Kaaman et al., 2007] . Down regulation of genes coding for subunits of respiratory complexes, decreased number of mitochondria with diminished mt DNA content, reduction of mitochondrial size, diminished levels of transcription factors involed in mitochondrial biogenesis and decreased mitochondrial respiration have been reported in human and animal models of obesity and type 2 diabetes [Abdul-Ghani & DeFronzo, 2008; Bonard et al., 2008; Choo et al., 2006; Dahlman et al., 2006; Heilbronn et al., 2007; Hojlund et al., MtDNA content can reduce adipocyte capacity for lipid storage, causing ectopic lipid accumulation in peripheral tissues such as muscle and liver [Dahlman et al., 2006] , Administration of thiazolidinediones, adrenergic stimulation, P-3 agonists, and CB1 blockade induces changes in mitochondrial content and remodeling in white adipocytes and causes an improvement in insulin sensitivity [Laplante et al., 2006; Tedesco et al., 2008; Wilson-Fritch et al., 2004] . Some evidence suggests that lack of insulin signaling does not reduce mitochondrial capacity in adipose tissue. 
Evidence for reduced muscle mitochondrial capacity in diabetes and obesity
Obesity is associated with reductions in citrate synthase, malate dehydrogenase, carnitine palmitoylotransferase 1 (CPT1), and cytochrome oxidase (COX) activity in the fasting state [Simoneau 8s Bouchard, 1995; Simoneau et al., 1995] and with parallel increases in activity of the glycolytic enzymes hexokinase and phosphofructokinase [Simoneau & Kelly, 1997] .
Another study has shown that the enzymatic activity of OXPHOS complex I, as assessed by the activity of rotenone-sensitive NADH:02 oxidoreductase, is reduced by about 40% in skeletal muscle biopsy samples from individuals with type 2 diabetes mellitus and by 20% in obese individuals [Ritov et al., consumption in permeabilized muscle fibers from obese individuals with type 2 diabetes mellitus has also been found [Boushel et al., 2007] . Electron microscopy has also demonstrated diminished mitochondrial size in obesity and diabetes [Kelly et al., 2002] partiularly in subsarcolemmal fractions [Ritov et al., 2005] . Nuclear magnetic resonance (NMR) spectroscopy has also been used to assess mitochondrial function in vivo and similar reductions in oxidative function were found in both insulin resistance and type 2 diabetes mellitus [Peterson et al., 2004] . In offsprings of type 2 diabetes subjects decreased rates of OXPHOS system have been observed by NMR studies and electron microscopic examinations of the same have indicated reduced mitochondrial mass [Befroy et al., 2007] . Decreases in maximal ADP-stimulated respiration (state 3, malate and pyruvate as substrates) in mitochondria isolated from obese subjects with diabetes melhtus as compared with obesity alone has been observed [Mogensen et al., 2007] . Further, reduction in mRNA expression levels for multiple nuclearencoded genes of the OXPHOS pathway as well as tracription factors of mitochondrial biogenesis is found in humans with type 2 diabetes melhtus [Mootha et al., 2003; Patti et al., 2003; Sreekumar et al., 2002] .
Evidence for reduced liver mitochondrial capacity in diabetes and obesity
Human obese and type 2 diabetes subjects are associated with reduced ex pression of seven of 25 genes encoding OXPHOS genes and the expression of these genes is inversely correlated with hepatic lipid accumulation and paralleled by reduction in expression of PGC-la and genes known to be 44 | P a g e ' o f Li regulated by thyroid hormone [Pihlajamaki et al., 2009 ]. Reduced expression of OXPHOS genes (e.g., COX7C, ATP5C1) is also observed in mice fed a high-fat diet and normalized by acute therapy with thyroid hormone T3 [Pihlajakami et al., 2009] . Whereas in contrast, studies in Japanese individuals with established diabetes mellitus and modest obesity (BMI 27 kg/m2) have shown a modestly increased expression of multiple genes within all complexes of OXPHOS complexes, in parallel with BMI and insulin resistance (measured by homeostasis model assessment of insulin resistance, HOMA-IR) [Takamura et al., 2008] and is also positively correlated with expression of several genes linked to mitochondrial biogenesis (e.g., PGC-la, ERR a, NRF, thyroid hormone receptor) and both ROS generation (e.g., NADPH oxidase) and attenuation (e.g., glutathione peroxidase). Enzymatic activity of complexes I-V is reduced in liver extracts from patients with NASH and is inversely correlated with BMI and HOMA-IR [Greenfield et al., 2008; Perez-Carreras et al., 2003] . Moreover, NASH is characterized by prominent abnormalities in mitochondrial ultrastructure such as increased size, loss of cristae, and paraciystalline inclusion bodies similar to those observed in some mitochondrial myopathies [Sanyal et al., 2001] . Reduced OXPHOS activity is also accompanied by increased tissue long-chain acylcamitines and reduced short-chain acylcamitines, despite normal CPT1 activity and increased expression of ^-oxidation genes [Kohjima et al., 2007; Misu et al., 2007] . Similarly, circulating [3hydroxybutyrate levels are increased in NASH [Sanyal et al., 2001] .
Systems for Oxidants Generation in obesity and type 2 diabetes.
In insulin resistance, excessive ROS/ RNS generation occurs as part of several, partially interrelated, pathophysiological mechanisms, which include metabolic overload-the overabundance of glucose and FFAs, inflammation, endoplasmic reticulum (ER) stress and the unfolded protein response (UPR), and dysregulated hormonal and growth factors regulation NADPH oxidases are membrane-bound emymatic complexes consisting of an electron transport chain that transfers electrons from the donor, cytosolic NADPH, to the acceptor, O2 and consequently, 02*" (and H2O2) are generated. ROS generation through NADPH oxidase is required for diverse physiological functions, including the response to various hormones and growth factors. Insulin-stimulated ROS production relies on NOX4 in adipocytes [Mahadev et al., 2004] and also on NOX2 expressed in skeletal and cardiac muscle [Heymes et al., 2003; Javesghani et al., 2002] . In adipose tissue of obese mice, NOX4 is found to be increased, as are p22phox, NOX2, as well as other components of its multiprotein complex (p67Phox, p47Phox, and p40phox) [Furukawa et al., 2004] . In adipose tissue of obese mice, NOX2 may arise either from obesity-associated upregulation of NOX2 in the adipose cells, or from phagocytic cells infiltrating this tissue in obesity [Weisberg et al., 2003; Xu et al., 2003] . Increased ROS production in 3T3-L1 adipocytes incubated with FFA or in hyperglycemic conditions is inhibited by chemical inhibitors thought to inhibit mainly NADPH oxidases [Furukawa et al., 2004; Wu et al., 2005] . In high fat fed mice, increased ROS production by adipocytes is inhibited by inhibitors of NADPH oxidases [Talior et al., 2005] . In humans, the expression of p47Phox in endothelial cells has been shown to corelate with body mass index and is significantly elevated in obese and overweight compared with lean controls [Silver et al., 2007] . It has been demonstrated that hypoxia [Suliman et al., 2004; Vallet et al., 2005] , inflammatory cytokines like TNF [Moe et al., 2006 ] and angiotensin n [Higashi et al., 2003; Wingler et al., 2006] , and ER stress [Pedruzzi et al., 2004] all induce upregulation of NOX4 mRNA and protein levels. All of these conditions or factors have also been implicated as causative factors in insulin resistance of adipose tissue and/or muscle [Gregor & Hotamisligil, 2007; Hosagai et al., 2007; Hotamisligil et al., 1999; Hwei et al., 2006] .
PPARy ligands used as insulin sensitizing agents have been shown to downregulate protein and mRNA expression of NOX4 (and NOX2) in endothelial cells [Hwang et al., 2005] .
Mitochondrial ROS generation
The mitochondrial electron transport chain is a major source of ROS production as discussed earlier. Increased mitochondrial ROS generation has been strongly implicated as a mediator between hyperglycemia and its pathological consequences in various tissues such as the vasculature [Nishikawa et al., 2000] , kidney [Kiritoshi et al., 2003] , neurons [Vincent et al., 2002; Vincent et al., 2004 ], retina [Lin et al., 2006 , and pancreatic beta cells [Sakai et al., 2003] . In 3T3-L1 adipocytes, high glucose has been shown to induce mitochondrial ROS, which mediated insulin resistance and activation of inflammatory pathways [Lin et al., 2005] . Increased reactive oxygen species production with lower abundance of complex I subunits and carnitine palmitoyltransferase lb protein despite normal mitochondrial respiration have been shown in mitochondria isolated from insulin-resistant human skeletal muscle [Lefort et al., 2010] , In another study, it has shown that the mitochondrial mass, membrane potential, and superoxideproduction are not changed in diabetic myotubes compared to lean controls 48 | P a g e ' of Li but H2O2 production and ATP production are significantly reduced [Minet 8s Gaster, 2011] . A recent study has proposed that in muscle of diet-induced insulin resistant mice, mitochondrial dysfunction is in fact a consequence, not the cause, of increased ROS production [Bonnard et al., 2008] .
Endoplasmic reticulum ROS production
The ER recently has attracted attention as a source of ROS generation [Bashan et al., 2009] . It is estimated that oxidative protein folding may account for as much as 25% of total cellular ROS generation [Cullman 85 Diehl, 2006; Malhotra 85 Kaufman, 2007] . When the requirement for ERsupported protein folding increases, whether as a consequence of increased demand for newly synthesized proteins or secondary to accumulation of misfolded proteins that initiate the unfolded protein response (UPR), ERderived ROS generation may also increase [Malhotra 8s Kaufman, 2007] Oxidative protein folding in the ER requires an electron transfer chain, which is less characterized than that in mitochondrial respiration, but share some common features. Electrons freed from the two cysteines that form a disulfide bond are donated to ER oxidoreductases like protein disulfide isomerase (PDI), then to ER oxidoreductin 1 (Erol), a flavin adenine dinucleotide (FAD)-containing protein, and finally, to molecular oxygen [Tu & Weissman, 2004] , ER stress has been proposed as a putative mechanism for insulin resistance, particularly in adipose tissue and the liver [Ozcan et al., 2004; Ozcan et al., 2006] . In nutritional and genetic models of obesity, adipose tissue exhibit markers of increased ER stress including phosphorylation of eIF2a, PERK, and elevated expression of the ER chaperone GRP78 [Ozcan et al., 2004] , IRE-med:ated phosphorylation of the stress-activated MAP kinase JNK is thought to be the molecular mechanism connecting ER stress and impaired insulin signaling [Ozcan et al., 2004] 
Fig. 14 ROS generation by the ER and its interrelations to mitochondrial ROS generation. ROS can
be generated in the ER as part of oxidative protein folding. To generate correctly folded protein with disulfide bonds formed between the correct cysteines (in green), electrons are donated to oxidoreductases (PDI, Erol) and ultimately to molecular oxygen, yielding FEO or ROS. When incorrect disulfide bonds form (in orange), they need to be reduced by GSH, resulting in a further decrease of GSH/GSSG ratio, altering the redox state within the ER. Alternatively, misfolded proteins can be directed to degradation through ER-associated degradation machinery (ERAD). Accumulation of misfolded proteins in the ER initiates the unfolded protein response (UPR), part of which is programmed to enhance antioxidant defense. Calcium ions released from the ER can augment mitochondrial ROS generation. This occurs through the elevation in electron donors to the electron transport (respiratory) chain through the stimulation of the tricarboxylic acid cycle. In addition, calcium ions increase cytochrome c release, impairing electron transfer and increasing ROS generation. This in turn can impair respiratory complexes, further augmenting ROS generation. ATF6, activating transcription factor 6; ATF4, activating transcription factor 4; eIF2a, eukaryotic translational initiation factor 2a; ERAD, ERassociated degradation; IRE, inositol-requiring enzyme-1; Nrf2, nuclear respiratory factor 2; ox/red-Erol, ER oxidoreductin 1; ox/red-PDI, oxidized/reduced protein disulfide iscmerase; PERK, PKR-like eukaryotic initiation factor 2a kinase; XBP1, X-box protein 1. [Bashan et al., 2009] 
Role of oxidative stress in type 2 diabetes and obesity
Oxidative stress plays a pivotal role in the development and progression of diabetes and its complications due to increased production of free radicals 
